Company
APT Medical, Inc.
Headquarters: Shenzhen, China
Employees: 1,511
Market Cap
CN¥42.94 Billion
CNY as of July 1, 2025
US$5.99 Billion
APT Medical, Inc. Categories
China Healthcare Medical DevicesChina Healthcare China Medical Devices
Top Competitors by Market Capitalization
Industry: Medical Devices
| Company | Market Cap (USD) |
|---|---|
| Abbott | $233.33 B |
| Boston Scientific Corporation | $154.34 B |
| Stryker | $151.06 B |
| Medtronic | $113.25 B |
| Edwards Lifesciences Corporation | $45.05 B |
Sector:
| Company | Market Cap (USD) |
|---|---|
| Lilly | $699.59 B |
| Johnson & Johnson | $374.29 B |
| AbbVie | $336.94 B |
| Novo Nordisk | $309.91 B |
| UnitedHealth Group | $279.90 B |
Detailed Description
APT Medical Inc. engages in the research and development, manufacture, and sale of invasive interventional medical devices for cardiovascular and cerebrovascular diseases worldwide. The company offers electrophysiological catheter delivery systems, as well as radiofrequency ablation and mapping catheters; and vascular intervention products, such as diagnostic and treatment products, and intervention accessories. It also provides OEM/ODM services to catheter and metal products, as well as accessories. The company was founded in 2002 and is headquartered in Shenzhen, China.
Financials
| Last Financial Reports Date | March 31, 2025 |
| Revenue TTM | CN¥2.17 B |
| EBITDA | CN¥833.5 M |
| Gross Profit TTM | CN¥1.57 B |
| Profit Margin | 32.93% |
| Operating Margin | 36.81% |
| Quarterly Revenue Growth | 23.90% |
Stocks & Indices
APT Medical, Inc. has the following listings and related stock indices.
Stock: SSE: 688617 wb_incandescent